Testing the variability of PSA expression by different human prostate cancer cell lines by means of a new potentiometric device employing molecularly antibody assembled on graphene surface

Tânia S C R Rebelo, João P. Noronha, Marco Galésio, Hugo Santos, Mário Diniz, M. Goreti F Sales, Maria H. Fernandes, João Costa-Rodrigues

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Prostate Specific Antigen (PSA) is widely used as a biomarker for prostate cancer. Recently, an electrochemical biosensor for PSA detection by means of molecularly imprinted polymers (MIPs) was developed. This work evaluated the performance and the effectiveness of that PSA biosensor in screening the biomarker PSA in biological media with complex composition, collected from different human prostate cell line cultures. For that, the prostate cancer LNCaP and PC3 cells, and the non-cancerous prostate cell line PNT2 were cultured for 2, 7 and 14 days in either α-MEM or RPMI in the presence of 10% or 30% fetal bovine serum. Human gingival fibroblasts were used as a non-cancerous non-prostatic control. The different culture conditions modulated cellular proliferation and the expression of several prostate markers, including PSA. The electrochemical biosensor was able to specifically detect PSA in the culture media and values obtained were similar to those achieved by a commercial Enzyme-Linked Immunosorbent Assay (ELISA) kit, the most commonly used method for PSA quantification in prostate cancer diagnosis. Thus, the tested biosensor may represent a useful alternative as a diagnostic tool for PSA determination in biological samples.

Original languageEnglish
Pages (from-to)1069-1078
Number of pages10
JournalMaterials Science & Engineering C-Materials For Biological Applications
Volume59
DOIs
Publication statusPublished - 1 Feb 2016

Keywords

  • Electrochemical biosensor
  • Prostate cell lines
  • Prostate Specific Antigen

Fingerprint

Dive into the research topics of 'Testing the variability of PSA expression by different human prostate cancer cell lines by means of a new potentiometric device employing molecularly antibody assembled on graphene surface'. Together they form a unique fingerprint.

Cite this